Press Releases Mangoceuticals, Inc.

Equities

MGRX

US56270V1061

Real-time Estimate Cboe BZX Other stock markets 01:49:57 2024-05-23 pm EDT			5-day change	1st Jan Change
0.488 ^USD	+6.09%		+111.27%	+67.93%

May. 21	Sector Update: Health Care Stocks Advance Late Afternoon	MT
May. 21	Sector Update: Health Care	MT

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

MangoRx Engages Renown International Digital and Performance Marketing Company Crakmedia to Champion its Digital Marketing Efforts	08:30am	AQ
MangoRx to Introduce Oral Semaglutide and Tirzepatide in Response to Increasing Patient Demand for GLP-1 Medications	May. 21	AQ
MangoRx Reports Revenue Growth of 108% in Q1 2024 Fueled by Amplified Customer Acquisition and Early Market Penetration	May. 16	AQ
Mangoceuticals Granted 180-Day Extension to Meet Nasdaq Minimum Bid Price Requirement and Conditional Approval of Compliance with Nasdaq’s Minimum Stockholders’ Equity Requirement	May. 02	AQ
Mangoceuticals Acquires Global Patent Portfolio to Revolutionize Preventive Care	Apr. 25	AQ
Mangoceuticals Subsidiary, MangoRx Mexico, Executes Technical Agreement with Mexican Pharmaceutical Manufacturer for Initial Development and Production of its Mango Erectile Dysfunction (ED) Products	Apr. 12	AQ
MangoRx Officially Launches ‘PRIME’ by MangoRx, Powered by Kyzatrex®️ FDA Approved Oral Testosterone Replacement Therapy (TRT) Treatment	Mar. 12	AQ
MangoRx Launches Direct-To-Clinics Sales Division to Drive and Fuel Customer Acquisition and Revenue Growth	Feb. 20	AQ
MANGORX AWARDS SAN FRANCISCO TEAM FREE MANGORX ED PRODUCTS FOR ONE YEAR FOLLOWING BIG GAME LOSS TO KANSAS CITY	Feb. 13	AQ
MANGORX TO OFFER THE BIG GAME’S LOSING TEAM A FREE ONE YEAR SUPPLY OF ITS ED PRODUCT, MANGO, TO HELP RAISE… SPIRITS	Feb. 06	AQ
MangoRx Accepting Pre Orders for its “PRIME”, by MangoRx, Powered by Kyzatrex®️ FDA Approved Oral Testosterone Replacement Therapy (TRT) Product	Feb. 05	AQ
MangoRx’s Brand and Products to be Featured by Barstool Sports in Week of Programming Around the Biggest Sports Event of the Year on February 11	Jan. 19	AQ
Mangoceuticals (MGRX) Blazes New Trails in Men's Health: Expands Global Reach and Innovates with Strategic Partnerships and Public Offering	Dec. 29	AQ
Mangoceuticals (MGRX) Charting New Frontiers in Men's Health and Telemedicine Innovation	Dec. 27	AQ
Mangoceuticals Inc (MGRX) Expands Its Horizons: A Deep Dive into Recent Developments	Dec. 21	AQ
Mangoceuticals ($MGRX) Poised for Growth: Strategic Expansion and Public Offering Set Stage for Market Surge	Dec. 19	AQ
Mangoceuticals, Inc. Announces Pricing of $1,200,000 Public Offering	Dec. 15	AQ
InvestorBrandMedia: Mangoceuticals ($MGRX) Partners with Marius Pharmaceuticals: A Strategic Leap in Men's Health Market	Dec. 14	AQ
MANGOCEUTICALS TO INTRODUCE “PRIME”, POWERED BY KYZATREX®️ (CIII TESTOSTERONE UNDECANOATE CAPSULES), FOR AN FDA APPROVED ORAL TESTOSTERONE REPLACEMENT THERAPY (TRT) PRODUCT	Dec. 13	AQ
InvestorBrandMedia: Mangoceuticals, Inc. (MGRX) Expands Reach: Launches New Hair Growth Product 'Grow' and Strengthens Presence in Latin America with MangoRx Mexico	Dec. 12	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Mangoceuticals, Inc.

Equities

MGRX

US56270V1061

Press Releases

Filters